Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...

Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery April 30, 2026 8:30 AM ...

As AI billionaires cash in, they’re already gearing up to sell the public on a feel-good story no one asked for and even ...

OpenAI has launched GPT-Rosalind, a large language model fine-tuned for life sciences research, aimed at tasks from genomic analysis to experimental protocol design. The model reportedly leads ...

Enterprise intent to adopt hybrid retrieval tripled from 10.3% to 33.3% in Q1 as first-gen RAG architecture failed at agentic ...

For R&D leaders evaluating AI investments, I’d offer one piece of advice: Before spending more on models, look hard at your ...

Breaking news from the worlds of technology and entertainment, and expert reviews of the latest consumer tech products.

For premenopausal women with ER-positive early breast cancer, even if chemotherapy or tamoxifen are given, OFS significantly reduces the 15-year risk of recurrence and death.